Skip to Content
Søg Menu
Hildur Helgadottir

ESMO 2025: Superior Outcomes With Reduced NIVO+IPI Dose in Advanced Melanoma

/ Hildur Helgadottir
ESMO25Melanom Play the Video

Cardiotoxicity in BRAF/MEK-Treated Melanoma: A Manageable but Underrecognized Risk

/ Jonas K. Oddershede / Rasmus Blechingberg Friis
Melanom
Marco Donia

Adjuvant Immunotherapy of Melanoma: The Current Status and Outlook for the Next Few Years

/ Marco Donia
Melanom Play the Video

Ten-Year Survival Data from a Groundbreaking Trial for the Treatment of Metastatic Melanoma

/ BestPractice Nordic
ESMO24Melanom

The Ultimate Proof That Immunotherapy Can Be Curative for Metastatic Malignant Melanoma

/ BestPractice Nordic
ESMO24Melanom
Rasmus Friis

Fejring af langtidsdata for behandling af metastatisk malign melanom – og døren til neoadjuverende behandling er ved at åbne sig

/ Rasmus Blechingberg Friis
ESMO24Melanom Play the Video
Marco Donia

Significant Updates on Neoadjuvant Treatments for Stage 3 Melanoma

/ Marco Donia
ESMO24MelanomImmunterapi Play the Video
Teo Helkkula

No Significant Changes in Incidence or Survival Rates of Acral Melanoma in Sweden

/ Teo Helkkula
EADV24Melanom Play the Video

EADV24: Breakthrough in Early Melanoma Detection Using Tumour-Specific Antibodies

/ Sofie Pohl
EADV24Melanom
Ebba Wennberg

Individuals With Radically Excised Thin Melanomas May Have Unnecessary Treatment During Wide Local Excision

/ Ebba Wennberg
EADV24Melanom Play the Video
Hildur Helgadottir

The Effect of Adjuvant Treatment on Overall Survival in Melanoma Stage III Patients

/ Hildur Helgadottir
ESMO24Melanom Play the Video
Hanna Grauers Wiktorin

Objective Responses and Stable Disease in Patients with Immunotherapy Refractory Advanced Malignant Melanoma

/ Hanna Grauers Wiktorin
ESMO24Melanom Play the Video
Hent flere
Back to top